Angioimmunoblastic T-cell lymphoma unmasked by treatment with dupilumab

Angioimmunoblastic T-cell lymphoma unmasked by treatment with dupilumab

Bibliographic Details
Main Authors:	Zi-Yi Choo, BS, Adesola A. Akinyemi, MD, MPH, Thomas Cibull, MD, Stephanie Mehlis, MD, Jason B. Waldinger, MD
Format:	Article
Language:	English
Published:	Elsevier 2023-03-01
Series:	JAAD Case Reports
Subjects:	angioimmunoblastic T-cell lymphoma atopic dermatitis biologics dupilumab medical dermatology peripheral T-cell lymphoma
Online Access:	http://www.sciencedirect.com/science/article/pii/S235251262300019X

Similar Items

Relapsed angioimmunoblastic T-cell lymphoma presenting as psoriasiform dermatitis
by: Spencer McClure, MD, et al.
Published: (2023-03-01)

Did dupilumab unmask smoldering mycosis fungoides?
by: Michelle Toker, BS, et al.
Published: (2023-08-01)

Tumors in the setting of dupilumab use: A review of the literature
by: Shumeng Guo, et al.
Published: (2025-01-01)

Case of angioimmunoblastic T-cell lymphoma presenting as peripheral and bone marrow plasmacytosis: A diagnostic conundrum
by: Deepika Gupta, et al.
Published: (2024-04-01)

Impact of Epstein-Barr Virus on Peripheral T-Cell Lymphoma Not Otherwise Specified and Angioimmunoblastic T-Cell Lymphoma
by: Tong-Yoon Kim, et al.
Published: (2022-01-01)

Therapeutic Effect of CAOLD Chemotherapy Regimen on Patients With Relapsed/Refractory Angioimmunoblastic T-Cell Lymphoma: A Case Study
by: Yu Liu, et al.
Published: (2022-01-01)

Cutaneous involvement in angioimmunoblastic T-cell lymphoma
by: Papadavid Evangelia, et al.
Published: (2010-01-01)

Acceleration of cutaneous T-cell lymphoma following dupilumab administration
by: Kristen Russomanno, MD, et al.
Published: (2021-02-01)

Successful Treatment of Atopic Dermatitis with Dupilumab in a Patient with Non-Hodgkin’s Lymphoma
by: YunMi Qiu, et al.
Published: (2022-01-01)

Recent Advances in Diagnosis and Therapy of Angioimmunoblastic T Cell Lymphoma
by: Mostafa F. Mohammed Saleh, et al.
Published: (2021-12-01)

Epstein-Barr virus-positive, CD30-positive, diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma
by: Marc Grossman, MD, et al.
Published: (2022-07-01)

Hypercalcemia as a rare presentation of angioimmunoblastic T cell lymphoma: a case report
by: Sana Chams, et al.
Published: (2018-04-01)

Use of bronchoalveolar lavage in diagnosing angioimmunoblastic T‐cell lymphoma: A case report
by: Gaku Yamamoto, et al.
Published: (2022-04-01)

EBV-Related Diffuse Large B-Cell Lymphoma in a Patient with Angioimmunoblastic T-Cell Lymphoma
by: Cem Şimşek, et al.
Published: (2019-02-01)

Angioimmunoblastic T-Cell Lymphoma: A Diagnostic Challenge
by: Jorge Ocampo-Garza, et al.
Published: (2014-12-01)

Is Dupilumab a chance for patients with moderate to severe atopic dermatitis? Literature review
by: Paweł Iwańczuk
Published: (2024-02-01)

Eosinophilic Pleural Effusion as the First Presentation of Angioimmunoblastic T Cell Lymphoma
by: Chia-Jung Chang, et al.
Published: (2007-01-01)

Chemotherapy combined with radiotherapy for successful treatment of angioimmunoblastic T-cell lymphoma: a case report
by: Yudi Xiong, et al.
Published: (2020-10-01)

Angioimmunoblastic T-cell lymphoma presenting with an acute serologic Epstein-Barr virus profile
by: Timothy Beer, et al.
Published: (2015-06-01)

Pulmonary Arterial Hypertension as an Unusual Presentation of Angioimmunoblastic T-Cell Lymphoma: A Case Report
by: Jiyoon Jung
Published: (2024-08-01)

Vitiligo during dupilumab therapy
by: Vincenzo Picone, MD, et al.
Published: (2023-06-01)

Kawasaki disease as the presenting featare of angioimmunoblastic lymphoma
by: S.Alle Yasin, et al.
Published: (2005-01-01)

A rare case of aggressive cytotoxic T-cell lymphoma in a patient on dupilumab
by: Renat Ahatov, BSA, et al.
Published: (2022-06-01)

Composite Angioimmunoblastic T-Cell Lymphoma and Diffuse Large B-Cell Lymphoma Presenting with Distributive Shock
by: Nisha Hariharan, et al.
Published: (2023-11-01)

Case Report: Pure Red Cell Aplasia due to Angioimmunoblastic T-Cell Lymphoma
by: Marina Vitorino, et al.
Published: (2020-02-01)

Inactivation of FOXO1 induces T follicular cell polarization and involves angioimmunoblastic T cell lymphoma
by: Meifang Xu, et al.
Published: (2019-12-01)

Real-world study and prognostic analysis of angioimmunoblastic T-cell lymphoma
by: Suxiao Li, et al.
Published: (2024-10-01)

Epstein–Barr virus positive diffuse large B‐cell lymphoma transformed into angioimmunoblastic T‐cell lymphoma after treatment
by: Chaoyu Wang, et al.
Published: (2021-05-01)

Angioimmunoblastic T-Cell Lymphoma after Treatment of Classic Hodgkin Lymphoma: A Case Report
by: Ken Tanaka, et al.
Published: (2023-11-01)

Angioimmunoblastic T-cell lymphoma associated with immune checkpoint inhibitor treatment
by: Taylor C. Duke, MD, et al.
Published: (2020-12-01)

COMPARATIVE ANALYSIS OF SEROLOGICAL MARKERS OF HERPES VIRUSES AND QUANTITATIVE IMMUNOGLOBULINOPATHIES IN PRIMARY PATIENTS WITH ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA
by: N. G. Chernova, et al.
Published: (2018-08-01)

The Application of Dupilumab to Pediatric Patients Aged 6–11yrs with Moderate-to-Severe Atopic Dermatitis Whose Disease is Not Adequately Controlled: The Clinical Data so Far
by: Balboul S, et al.
Published: (2023-05-01)

Comparison of chemotherapy and chidamide combined with chemotherapy in patients with untreated angioimmunoblastic T-cell lymphoma
by: Simeng Gu, et al.
Published: (2024-04-01)

REACTIVE PLASMACYTOSIS AT THE ONSET OF ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA. CASE REPORT
by: N. G. Chernova, et al.
Published: (2018-02-01)

Predicting the efficiency of chidamide in patients with angioimmunoblastic T-cell lymphoma using machine learning algorithm
by: Chunlan Zhang, et al.
Published: (2024-08-01)

Dupilumab in patients with moderate to severe atopic dermatitis and multiple sclerosis
by: Maria Esposito, MD, et al.
Published: (2023-01-01)

Angioimmunoblastic T-cell Lymphoma: A Mimic for Lupus
by: Hui Boon Tay, et al.
Published: (2020-07-01)

Case Report: Immune Microenvironment and Mutation Features in a Patient With Epstein–Barr Virus Positive Large B-Cell Lymphoma Secondary to Angioimmunoblastic T-Cell Lymphoma
by: Fen Zhang, et al.
Published: (2022-07-01)

Clinical trial: Chidamide plus CHOP improve the survival of newly diagnosed angioimmunoblastic T-cell lymphoma
by: Xiangping Zong, et al.
Published: (2024-08-01)

CUTANEOUS MANIFESTATIONS OF ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA
by: N. G. Chernova, et al.
Published: (2018-06-01)